田舍,江建新,刘兴贵,张浩,张宏,喻超,孙诚谊
TIAN She,JIANG Jianxin,LIU Xinggui,ZHANG Hao,ZHANG Hong,YU Chao,SUN Chengyi

• 1:贵阳医学院附院肝胆外科

摘要(Abstract)：

目的:探讨血糖紊乱与胰腺癌患者生存时间的关系。方法:回顾性分析44例胰腺癌患者的临床资料,根据血糖水平分成血糖正常组、糖尿病前期组及糖尿病组,观察各组患者的年龄分布、通过随访了解糖代谢紊乱与胰腺癌患者生存时间的关系。结果:本组胰腺癌患者伴糖尿病前期的比例为27.27%,胰腺癌伴糖尿病的比例为31.84%,胰腺癌患者伴有糖耐量异常患者生存时间长于胰腺癌合并糖尿病患者(P<0.05),胰腺癌患者不伴有糖耐量异常的生存时间长于合并糖尿病患者(P<0.05)。结论:胰腺癌患者出现糖代谢紊乱的比例较高,糖代谢紊乱的胰腺癌患者生存时间明显短于无糖代谢异常的患者。
Objective: To explore the relationship between glycemia disorder and survival time of patients with pancreatic carcinoma,and so as to provide clues for early prevention of pancreatic carcinoma. Methods: A total of 44 patients with pancreatic carcinoma were divided into three groups: normal blood glucose gruop,prediabetes group and diabetes group. The age distribution of the three groups was observed,and the relationship between glycemia disorder and survival time of patients with pancreatic carcinoma was analyzed. Results: The ratio of pancreatic carcinoma accompanying prediabetes was 27. 27%,and The ratio of pancreatic carcinoma accompanying diabetes was 31. 84%,the survival time of pancreatic cancer patients with impaired glucose tolerance was longer than that of pancreatic cancer patients with diabetes( P < 0. 05),the survival time of pancreatic cancer patients without impaired glucose tolerance was longer than that of pancreatic cancer patients with diabetes( P < 0. 05).Conclusion: The incidence of glycemia disorder in patients with pancreatic carcinoma is relatively high,the survival time of pancreatic cancer patients with glycemia disorder is shorter than that of pancreatic cancer patients without impaired glucose tolerance.

关键词(KeyWords)： 胰腺肿瘤;癌;糖尿病;生存时间;生活质量
pancreatic neoplasms;carcinoma;diabetes;survival time;quality of life

Abstract:

Keywords:

基金项目(Foundation): 国家国际科技合作专项资助(2014DFA31420);; 国家自然科学基金资助项目(81160311);; 贵州省科技厅项目[黔科合(2010)3149];; 贵州省卫生厅科学技术基金项目(GZWKJ2010-1-037)

作者(Author): 田舍,江建新,刘兴贵,张浩,张宏,喻超,孙诚谊
TIAN She,JIANG Jianxin,LIU Xinggui,ZHANG Hao,ZHANG Hong,YU Chao,SUN Chengyi

DOI: 10.19367/j.cnki.1000-2707.2015.02.005

参考文献(References)：

• [1]Tan爫ǎu A,Negrean V,Alexescu T,et al.Two different types of diabetes mellitus in pancreatic cancer population.Comparative study between new onset and long standing diabetes mellitus on 76 patients with pancreatic cancer[J].Rom J Intern Med,2014(1):18-23.
• [2]Luo J,Xiao L,Wu C,et al.The incidence and survival rate of population-based pancreatic cancer patients:Shanghai Cancer Registry 2004-2009[J].PLo S One,2013(10):e76052.
• [3]Ahn Jl,Lee JK.Pancreatic cancer-associated diabetes mellitus:prevalence and temporal association with diagnosis of cancer[J].Rean J Gastroenterol,2013(5):263-266.
• [4]Yang W,Hl J,Weng J,et al.China National Diabetes and Metabolic Disorders Study Group.Prevalence of diabetes among men and women in China[J].N EIlgl J Med,2010(362):1090-1101.
• [5]Wolpin BM,Bao Y,Qian ZR,et al.Hyperglycemia,insulin resistance,impaired pancreaticβ-cell function,and risk of pancreatic cancer[J].J Natl Cancer Inst,2013(14):1027-1035.
• [6]Kim SK,Kim HJ,Kim T,et al.Effectiveness of 3-day continuous glucose monitoring for improving glucose control in type 2 diabetic patients in clinical practice[J].J Diabetes Metab J,2014(6):49-55.
• [7]He XD,Wu Q,Liu W,et al Association of metabolic syndromes and risk factors with ampullary tumors development:a case-control study in China[J].World J Gastroenterol,2014(28):2800-2803.
• [8]孙诚谊,朱海涛.胆囊功能的新认识[J].世界华人消化杂志,2012(33):3181-3185.
• [9]Zhang C,Yang G,Ling Y,et al.The early diagnosis of pancreatic cancer and diabetes:what's the relationship[J].J Gastrointest Oncol,2014(6):481-488.

文章评论(Comment)：